NGL FINE CHM share price has plunged 5% and is presently trading at Rs 2,500.0.
Meanwhile, the BSE HEALTHCARE index is at 41,035.2 .
Among the top losers in the BSE HEALTHCARE index today are Cadila Healthcare (down 1.9%) and Divis Laboratories (down 1.6%).
ASTRAZENECA PHARMA (up 4.4%) and Natco Pharma (up 2.3%) are among the top gainers today.
Over the last one year, NGL FINE CHM has moved up from Rs 2,140.9 to Rs 2,500.0, registering a gain of Rs 359.1 (up 16.8%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,485.8 to 41,035.2, registering a gain of 44.1% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 111.7%), Jubilant Pharmova (up 110.7%) and SUVEN PHARMACEUTICALS (up 108.7%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,622.2 .
The top losers among the BSE Sensex today are HDFC Bank (down 2.3%) and Asian Paints (down 0.6%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.
In the meantime, NSE Nifty is at 24,330.5 (down 0.1%). HDFC Bank and Divis Laboratories are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,995.8 to 79,622.2, registering a gain of 13,626.4 points (up 20.6%).
NGL FINE CHM net profit grew 32.2% YoY to Rs 123 million for the quarter ended March 2024, compared to a profit of Rs 93 million a year ago. Net sales rose 35.0% to Rs 998 million during the period as against Rs 739 million in January-March 2023.
For the year ended March 2024, NGL FINE CHM reported 101.6% increase in net profit to Rs 413 million compared to net profit of Rs 205 million during FY23. Revenue of the company grew 21.8% to Rs 3,387 million during FY24.
The current Price to earnings ratio of NGL FINE CHM, based on rolling 12 month earnings, stands at 37.4.
Equitymaster requests your view! Post a comment on "NGL FINE CHM Plunges 5%; BSE HEALTHCARE Index Down 0.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!